Life science & clinical diagnostics instruments

Merck Millipore Magna Nuclear RNA-binding Protein Immunoprecipitation (RIP) Kits

05 August, 2014 | Supplied by: Merck Pty Ltd

Merck Millipore has introduced the Magna Nuclear RNA-binding Protein Immunoprecipitation (RIP) kits. The kits are designed to allow the discovery and analysis of both coding and non-coding chromatin-associated RNAs.


Redbiotec and GE Healthcare collaborate on CMV vaccine

30 July, 2014

Biopharma company Redbiotec and multinational GE Healthcare Life Sciences are collaborating on a process which could lead to the development and production of new vaccines against cytomegalovirus (CMV).


Newlab Engineering CPA300 and CPA300 card processing instruments for DNA sample preparation

30 July, 2014 | Supplied by: Thermo Fisher Scientific

Newlab Engineering Card Processing Automation (CPA) technology is designed to prepare DNA samples for human identification in forensic, paternity and research laboratories.


Qiagen GeneRead DNAseq Leukemia V2 gene panel with SF3B1 biomarker

28 July, 2014 | Supplied by: QIAGEN Pty Ltd

Qiagen has acquired an exclusive global licence to the biomarker SF3B1 from the University of Tokyo. The biomarker is included in the company's GeneRead DNAseq Leukemia V2 gene panel for next-generation sequencing.


Biosensis Phospho-Sure RTD Neuronal extraction buffer

23 July, 2014 | Supplied by: Sapphire Bioscience

The Phospho-Sure RTD Neuronal extraction buffer, from Australian manufacturer Biosensis, is optimised for the extraction of phosphorylated proteins from neuronal and other soft tissues.


BioStatus DRAQ7 far-red fluorescent DNA dye

22 July, 2014 | Supplied by: Sapphire Bioscience

DRAQ7 is a non-toxic, far-red fluorescent DNA dye that only stains the nuclei in dead and permeabilised cells. The dye does not overlap with PE and homologues, making it a suitable replacement for common dyes such as propidium iodide and 7-AAD in cytotoxicity and cell viability assays.


DiaSorin Iam CMV assay

20 July, 2014 | Supplied by: DiaSorin Australia Pty Ltd

DiaSorin has launched a molecular assay for the rapid detection and quantification of cytomegalovirus (CMV). The DiaSorin Iam CMV assay is used to detect and quantify clinically relevant subtypes of CMV in human plasma, urine and cerebrospinal fluid (CSF).


Inexpensive assay detects fake malaria drugs

17 July, 2014

Chemists from Oregon State University (OSU) have created a simple, inexpensive assay which can tell whether or not one of the primary drugs being used to treat malaria is genuine.


Scientists sequence genome of cancer-causing parasite

17 July, 2014

An international team of scientists has sequenced the genome and characterised the genes of the Asian liver fluke, Opisthorchis viverrini.


Friends' similarities extend to their genes

16 July, 2014

It appears that we share more with our friends than we thought, with US researchers discovering that friends who are not biologically related still resemble each other genetically.


Clontech Guide-it products for CRISPR/Cas9 genome editing

16 July, 2014 | Supplied by: Scientifix Pty Ltd

CRISPR/Cas9 technology offers an efficient, simple system for targeted genome editing. Guide-it products are said to improve the CRISPR/Cas9 workflow by providing a streamlined method.


Qiagen GeneRead DNAseq V2 gene panels

16 July, 2014 | Supplied by: QIAGEN Pty Ltd

Qiagen has launched 14 GeneRead DNAseq V2 gene panels targeting an extensive range of cancer-related genes and gene regions, including 'focused' panels each targeting 8-25 genes, 'disease-specific' panels for 40-50 genes and 'comprehensive' panels for as many as 160 genes.


The flipping protein found at last?

11 July, 2014

US researchers believe they have answered the last major question in the effort to understand the pathway that leads to the creation of a bacterium’s cell wall. It is possible that their breakthrough could help lead to the wall's destruction and, with it, the eradication of various types of bacterial infection.


OGT CytoSure Embryo Screen Array

10 July, 2014 | Supplied by: Oxford Gene Technology (OGT)

Oxford Gene Technology (OGT) has launched a high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution, genome-wide aneuploidy and copy number detection in pre-implantation embryos.


The shrinking human genome

09 July, 2014

​Researchers from the Spanish National Cancer Research Centre (CNIO) have updated the number of human genes - those that can generate proteins - to 19,000. This is 1700 fewer genes than described in the most recent annotation.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd